Innovative therapeutics and patient-centric solutions serve aging populations amidst increasing thrombosis prevention awareness.
BOSTON, Oct. 25, 2023 /PRNewswire/ — The global antithrombotic/anticoagulant drugs market, valued at $29 billion in 2022, will reach $46 billion by 2028, BCC analysts project. The market’s expected CAGR between 2023 and 2028 is 7.9%. Market growth drivers include increased need for the drugs as obesity rates surge around the globe.
To keep up with the increasing demand, global pharmaceutical companies such as Bristol Myers Squibb, Johnson & Johnson, and Sanofi have led research and development and have invested heavily in low-molecular weight heparin (LMWH) anticoagulant drugs.
The report, Global Antithrombotic/Anticoagulant Drug Market, gives detailed insights into diverse categories of antithrombotic medications, including thrombin inhibitors, anticoagulants, and antiplatelets.
The report also explores:
- Antithrombotics market growth by region: While North America holds the highest share of the market, there has been lots of activity among antithrombotic drug manufacturers in China, India, Brazil and Indonesia.
- Market trends and forecasts: Thrombin inhibitors are expected to dominate the global antithrombotic market by the end of 2028.
- M&A activity: The report explores the increase in mergers and acquisitions over the last 5 years and its impacts.
Thrombotic diseases, peripheral vascular diseases, valvular heart diseases, and other cardiovascular diseases are, together, the leading cause of death worldwide. Download Global Antithrombotic/Anticoagulant Drug Market to get the lowdown on therapeutic forecasts for the next five years.
For further information or to make a purchase, please get in touch with [email protected].
About BCC Research
BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.
BCC Research LLC
49 Walnut Park, Building 2
Wellesley, MA 02481, USA
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email [email protected] or visit www.bccresearch.com/media to request access to our library of market research.
SOURCE BCC Research LLC
Originally published at https://www.prnewswire.com/news-releases/global-antithrombotic-drugs-market-will-grow-by-17-billion-over-the-next-6-years-bcc-research-forecasts-301967651.html
Images courtesy of https://pixabay.com